Aurion Biotech Appoints Dr. Michael Goldstein as President and Chief Medical Officer

By Staff
Wednesday, June 15, 2022 12:21 AM SEATTLE, BOSTON and TOKYO—Aurion Biotech has appointed Michael Goldstein, MD, MBA, as president and chief medical officer.

Shamir Execs Discuss Innovation, New Products, Partnerships and More in Exclusive Video Interviews With VM

By Staff
Monday, June 13, 2022 12:18 AM KIBBUTZ SHAMIR, Israel—In late May, just ahead of a celebration to mark the 50th anniversary of Shamir Optical Industry, Vision Monday met with leaders of the company at their corporate headquarters here. In exclusive, wide ranging video interviews, three of Shamir’s top executives—Yagen Moshe, CEO and president, Raanan Naftalovich, CEO and president of Shamir North America and Zohar Katzman, chief technical officer—discussed how the company has established and maintains its position as a vision technology innovator on a global scale.

Visiox Appoints Two Nationally Recognized Ophthalmologists to Board of Directors

By Staff
Thursday, June 9, 2022 12:15 AM TARRYTOWN, N.Y.—Visiox Pharma, LLC has appointed two new executives, Ehsan Sadri, MD, FACS and Tom Mitro to its board of directors.

Ocular Science Appoints Kip Crecca to Board of Directors

By Staff
Monday, June 6, 2022 12:15 AM EL SEGUNDO, Calif.—Kip Crecca, vice president of sales, North America at STAAR Surgical has joined the Ocular Science board of directors.

Zeiss Group Announces Changes to Executive Board of Carl Zeiss AG

By Staff
Friday, June 3, 2022 12:21 AM OBERKOCHEN, Germany—The Zeiss Group announced several changes to the executive board of Carl Zeiss AG. Dr. Matthias Metz, member of the executive board of Carl Zeiss AG and responsible for the Zeiss Consumer Markets segment, including Zeiss Vision Care, will switch to BSH Hausgerate GmbH, Munich.

CooperVision Appoints Drs. Arumugam and Hammond to Expanded R&D Roles in Myopia Control and Management

By Staff
Friday, May 27, 2022 12:24 AM SAN RAMON, Calif.—CooperVision, a leader in myopia management, has announced expanded roles for two prominent researchers, reinforcing the company’s commitment to combatting myopia, a chronic, progressive disease growing in both prevalence and severity.

Visiox Pharma Names Ophthalmic Industry Veteran Ryan S. Bleeks as CEO

By Staff
Friday, May 20, 2022 12:30 AM TARRYTOWN, N.Y.—Visiox Pharma, LLC., a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic therapeutics, has appointed Ryan S. Bleeks as chief executive officer.

Ocuco Appoints Carlo Rossetti as Senior Sales Executive for North America

By Staff
Friday, May 20, 2022 12:27 AM VANCOUVER, B.C.—Ocuco has announced the addition of Carlo Rossetti to its expanding North American team. He brings over 20 years of experience within the tech industry, including several years operating within the optical sector, to his new role at Ocuco.

Euclid Vision Names Dr. Zohra Fadli as Global Head of R&D and Clinical Affairs

By Staff
Thursday, May 19, 2022 12:15 AM STERLING, Va.—Euclid Vision Corp., a global leader in advanced orthokeratology and proactive myopia management initiatives, has appointed Zohra Fadli, PhD, as vice president of research and development & clinical affairs. Dr. Fadli brings decades of experience in medical device technology and vision care to her new role at Euclid, including an extensive history in delivering breakthrough ophthalmic contact lenses.

Visioneering Technologies Inc. Announces Changes to Commercial Organization

By Staff
Friday, April 29, 2022 12:21 AM ALPHARETTA, Ga.—Visioneering Technologies, Inc. (ASX: VTI), the Alpharetta, Ga.-based medical device company and producer of the NaturalVue Enhanced Multifocal 1 Day Contact Lenses, has announced several changes to the commercial organization within the company.

Industry Veteran John Fried Passes Away at 71

By Staff
Wednesday, April 27, 2022 12:18 AM WAUWATOSA, Wisc.—John Fried, a longtime optical industry executive, passed away peacefully in his home here on April 8 due to complications stemming from amyotrophic lateral sclerosis.

EssilorLuxottica Announces New Leadership Team for GrandVision Retail Group as Stephan Borchert Steps Down as CEO

By Staff
Monday, April 18, 2022 12:24 AM CHARENTON-LE-PONT, France, and SCHIPHOL, The Netherlands—With its acquisition of GrandVision completed, EssilorLuxottica (Euronext: EL) announced Friday that it has made changes to the GrandVision management team. Stephan Borchert and Willem Eelman have decided to step down from their roles as chief executive officer and chief financial officer of GrandVision, respectively, effective April 22.

Shamir Insight Announces Changes in Executive Leadership

By Staff
Monday, April 18, 2022 12:21 AM SAN DIEGO, Calif.—Shamir Insight announced several changes in its executive leadership, effective April 1. Pierson Ball, the company’s director of business and strategic development has been appointed vice president of sales.

Bryan Wolynski Named Chief Technology Officer at Lighthouse Guild

By Staff
Friday, March 18, 2022 12:18 AM NEW YORK—Bryan Wolynski, OD, FAAO, has been named chief technology officer at Lighthouse Guild, the leading organization dedicated to providing services that inspire people who are visually impaired to attain their goals. Dr. Wolynski will oversee all technology resources for the organization, including the recently opened Lighthouse Guild Technology Center.

CooperVision Specialty EyeCare Names Tony Sommer as General Manager, Americas

By Staff
Wednesday, March 16, 2022 12:27 AM SAN RAMON, Calif.—CooperVision Specialty EyeCare has appointed Tony Sommer Jr. as general manager, Americas. Sommer will lead the organization’s continued growth and projected category expansion across the U.S., Canada and Latin America, beginning this April, according to a CooperVision announcement this week. Sommer—who has two decades of industry-related experience—most recently served as senior vice president of sales and marketing for Visioneering Technologies Inc., where he led strategic planning and commercial operations for the company’s contact lens portfolio.